Niaspan, HDL and Assumptions
A week and a half ago the National Institutes of Health pulled the plug on a research study assessing the effect of long-acting niacin (Niaspan) on the risk...
HDL
New Cholesterol Drug Might Be Good News
There’s good news coming out of the world of cardiology drug research. In Chicago this last week at the annual meeting of the American Heart Association, Dr. Christopher...